Journals / Trends in pediatrics / 2021 / Cilt: 2 - Sayı: 2

A Newborn Admitted with Hyponatremia and Hyperkalemia Clinic and Diagnosed with Primary Hypoaldosteronism

Pages
94–98
Publication Date
2022-10-19
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Laboratory findings revealed hyponatremia, hyperkalemia, high plasma renin, and low aldosterone levels, while genetic analysis showed homozygous c.788T>A (p.Ile263Asn) variant in the CYP11B2 gene (NM_000498.3).

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Primary hypoaldosteronism is a rare autosomal recessive disorder that causes defects in aldosterone synthase enzyme activity due to an inactivating mutation in the CYP11B2 gene.
📊
Key Findings & Data:Laboratory findings revealed hyponatremia, hyperkalemia, high plasma renin, and low aldosterone levels, while genetic analysis showed homozygous c.788T>A (p.Ile263Asn) variant in the CYP11B2 gene (NM_000498.3).
💡
Conclusion & Impact:Early diagnosis and treatment are particularly important because primary hypoaldosteronism causes life-threatening electrolyte disorders and salt loss syndrome.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Primary hypoaldosteronism is a rare autosomal recessive disorder that causes defects in aldosterone synthase enzyme activity due to an inactivating mutation in the CYP11B2 gene. Patients with primary hypoaldosteronism exhibit symptoms such as vomiting, dehydration, feeding problems, and failure to thrive. This disease is characterized by hyponatremia, hyperkalemia, metabolic acidosis, high renin, and low aldosterone levels. It also causes salt loss syndrome in the newborn period. In this article, we described a newborn with primary hypoaldosteronism who showed feeding problems and weight loss. Laboratory findings revealed hyponatremia, hyperkalemia, high plasma renin, and low aldosterone levels, while genetic analysis showed homozygous c.788T>A (p.Ile263Asn) variant in the CYP11B2 gene (NM_000498.3). Our patient responded well to oral salt and fludrocortisone treatments. Early diagnosis and treatment are particularly important because primary hypoaldosteronism causes life-threatening electrolyte disorders and salt loss syndrome.

🔖

Cite This Article

Erdeve, Ş. S., Çetinkaya, S., Şakar, M., Barış, İ. A., Öktem, A., Zenciroğlu, A., Bundak, R. (2022). A Newborn Admitted with Hyponatremia and Hyperkalemia Clinic and Diagnosed with Primary Hypoaldosteronism. Trends in pediatrics, Cilt: 2 - Sayı: 2, 94–98. https://ajindex.com/articles/598897

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (9)

  1. Root AW. Disorders of aldosterone synthesis, secretion, and cellular function. Curr Opin Pediatr. 2014;26:480-6.
  2. Bizzarri C, Pedicelli S, Cappa M, Cianfarani S. Water balance and “Salt Wasting” in the first year of life: The role of aldosterone-signaling defects. Horm Res Paediatr. 2016;86:143-53.
  3. White PC. Aldosterone synthase deficiency and related disorders. In: Molecular and Cellular Endocrinology. 2004;217:81-7.
  4. Miao H, Yu Z, Lu L, et al. Analysis of novel heterozygous mutations in the CYP11B2 gene causing congenital aldosterone synthase deficiency and literature review. Steroids. 2019;150:108448.
  5. Üstyol A, Atabek ME, Taylor N, Yeung MC, Chan AOK. Case report corticosterone methyl oxidase deficiency Type 1 with normokalemia in an infant. J Clin Res Pediatr Endocrinol. 2016;8:356-9.
  6. Bonfig W, Schwarz HP. Blood pressure, fludrocortisone dose, and plasma renin activity in children with classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency followed from birth to 4 years of age. Clin Endocrinol (Oxf). 2014;81:871-5.
  7. Martinerie L, Viengchareun S, Delezoide AL, et al. Low renal mineralocorticoid receptor expression at birth contributes to partial aldosterone resistance in neonates. Endocrinology. 2009;150:4414-24.
  8. Laetitia M, Eric P, Laurence FLH, et al. Physiological partial aldosterone resistance in human newborns. Pediatr Res. 2009;66:323-8.
  9. Turan I, Kotan LD, Tastan M, Gurbuz F, Topaloglu AK, Yuksel B. Molecular genetic studies in a case series of isolated hypoaldosteronism due to biosynthesis defects or aldosterone resistance. Clin Endocrinol. (Oxf). 2018;88:799-805. https://doi.org/10.1111/cen.13603